Advertisement

Journal of Neurology

, Volume 255, Issue 10, pp 1549–1554 | Cite as

Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy

  • Giuseppe Plazzi
  • Francesca Poli
  • Christian Franceschini
  • Antonia Parmeggiani
  • Piero Pirazzoli
  • Filippo Bernardi
  • Emmanuel Mignot
  • Alessandro Cicognani
  • Pasquale Montagna
ORIGINAL COMMUNICATION

Abstract

We report on the outcome of intravenous high-dose immunoglobulin (IVIg) treatment in four children with narcolepsy and cataplexy, in whom the early diagnosis and the extreme disease severity were indications for this potentially efficacious therapy. One of four patients showed an objective and persistent improvement in clinical features during and after IVIg treatment. Our data partially support the recent report of the efficacy of IVIg treatment in early diagnosed narcolepsy with cataplexy and support the need for a controlled multicenter clinical trial on IVIg in narcolepsy.

Key words

narcolepsy with cataplexy intravenous immunoglobulins early treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Academy of Sleep Medicine (2005) International Classification of Sleep Disorders, 2nd ed.: Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester, IllinoisGoogle Scholar
  2. 2.
    Arii J, Kanbayashi T, Tanabe Y, Sawaishi Y, Kimura S, Watanabe A, Mishima K, Hishikawa Y, Shimizu T, Nishino S (2004) CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders. Neurology 63:2440–2442PubMedGoogle Scholar
  3. 3.
    Boehmer LN, Wu MF, John J, Siegel JM (2004) Treatment with immunosuppressive and antiinflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity diseases. Exp Neurol 188:292–299PubMedCrossRefGoogle Scholar
  4. 4.
    Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M (1994) Narcolepsy in children. Sleep 17:S17–S20PubMedGoogle Scholar
  5. 5.
    Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243PubMedCrossRefGoogle Scholar
  6. 6.
    Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367–2375PubMedCrossRefGoogle Scholar
  7. 7.
    Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M (2004) Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56:905–908PubMedCrossRefGoogle Scholar
  8. 8.
    Dauvilliers Y (2006) Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol 60:153PubMedCrossRefGoogle Scholar
  9. 9.
    Dodel R, Peter H, Walbert T, Spottke A, Noelker C, Berger K, Siebert U, Oertel WH, Kesper K, Becker HF, Mayer G (2004) The socioeconomic impact of narcolepsy. Sleep 27:1123–1128PubMedGoogle Scholar
  10. 10.
    Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B (2003) The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep 26:455–458PubMedGoogle Scholar
  11. 11.
    Fronczek R, Verschuuren J, Lammers GJ (2007) Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol 254:1607–1608PubMedCrossRefGoogle Scholar
  12. 12.
    Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, Mignot E, Shiromani PJ (2003) Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184:1010–1016PubMedCrossRefGoogle Scholar
  13. 13.
    Guy W (1976) Clinical Global Impression. ECDEU assessment manual for psychopharmacology, revised National Institute of Mental Health, Rockville, MDGoogle Scholar
  14. 14.
    Hecht M, Lin L, Kushida CA, Umetsu DT, Taheri S, Einen M, Mignot E (2003) Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep 26:809–810PubMedGoogle Scholar
  15. 15.
    Kadouri A, Corruble E, Falissard B (2007) The improved Clinical Global Impression Scale (iCGI): development and validation in depression. BMC Psychiatry 7:7PubMedCrossRefGoogle Scholar
  16. 16.
    Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M (2003) Clinical efficacy of highdose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 12:347–348PubMedGoogle Scholar
  17. 17.
    Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Daniel LL, Bailey D, Berry RB, Kapen S, Kramer M; Standards of Practice Committee of the American Academy of Sleep Medicine (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113–121PubMedGoogle Scholar
  18. 18.
    Serra L, Montagna P, Mignon E, Lugaresi E, Plazzi G (2008) Cataplexy features in childhood narcolepsy. Mov Disord 23:858–865PubMedCrossRefGoogle Scholar
  19. 19.
    Smith AJ, Jackson MW, Neufing P, McEvoy RD, Gordon TP (2004) A functional autoantibody in narcolepsy. Lancet 364:2122–2124PubMedCrossRefGoogle Scholar
  20. 20.
    Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474PubMedCrossRefGoogle Scholar
  21. 21.
    Thannickal TC, Siegel JM, Nienhuis R, Moore RY (2003) Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 13:340–351PubMedGoogle Scholar
  22. 22.
    The U.S. Xyrem Multicenter Study Group (2002) A randomized, double blind, placebo controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25:42–49Google Scholar
  23. 23.
    Tucci V, Stegagno L, Vandi S, Ferrillo F, Palomba D, Vignatelli L, Ferini-Strambi L, Montagna P, Plazzi G (2003) Emotional information processing in patients with narcolepsy: a psychophysiologic investigation. Sleep 26:558–564PubMedGoogle Scholar
  24. 24.
    Yoss RE, Daly DD (1960) Narcolepsy in children. Pediatrics 25:1025–1033PubMedGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Giuseppe Plazzi
    • 1
  • Francesca Poli
    • 1
  • Christian Franceschini
    • 1
  • Antonia Parmeggiani
    • 1
  • Piero Pirazzoli
    • 2
  • Filippo Bernardi
    • 2
  • Emmanuel Mignot
    • 3
  • Alessandro Cicognani
    • 2
  • Pasquale Montagna
    • 1
  1. 1.Sleep Disorders Center, Dept. of Neurological SciencesUniversity of BolognaBolognaItaly
  2. 2.Dept. of PediatricsUniversity of BolognaBolognaItaly
  3. 3.Center for NarcolepsyStanford UniversityCaliforniaUSA

Personalised recommendations